Hazlett, Burt & Watson’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
1,840
+316
| +21% | +$246K | 0.59% | 42 |
|
|
2025
Q1 | $1.26M | Buy |
1,524
+26
| +2% | +$21.5K | 0.57% | 46 |
|
|
2024
Q4 | $1.16M | Buy |
1,498
+40
| +3% | +$30.9K | 0.51% | 47 |
|
|
2024
Q3 | $1.29M | Buy |
1,458
+109
| +8% | +$96.7K | 0.59% | 36 |
|
|
2024
Q2 | $1.23M | Buy |
1,349
+58
| +4% | +$52.8K | 0.63% | 34 |
|
|
2024
Q1 | $1M | Buy |
1,291
+85
| +7% | +$66.1K | 0.6% | 34 |
|
|
2023
Q4 | $703K | Buy |
1,206
+427
| +55% | +$249K | 0.47% | 44 |
|
|
2023
Q3 | $419K | Buy |
779
+159
| +26% | +$85.5K | 0.31% | 67 |
|
|
2023
Q2 | $290K | Buy |
620
+269
| +77% | +$126K | 0.22% | 96 |
|
|
2023
Q1 | $121K | Buy |
351
+21
| +6% | +$7.24K | 0.1% | 175 |
|
|
2022
Q4 | $121K | Buy |
330
+1
| +0.3% | +$367 | 0.11% | 168 |
|
|
2022
Q3 | $107K | Hold |
329
| – | – | 0.1% | 172 |
|
|
2022
Q2 | $107K | Buy |
329
+1
| +0.3% | +$325 | 0.1% | 189 |
|
|
2022
Q1 | $94K | Buy |
+328
| New | +$94K | 0.07% | 217 |
|